Official Publications Intellia Therapeutics, Inc.
Equities
NTLA
US45826J1051
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.49 USD | -2.46% |
|
+2.74% | +50.06% |
| Mar. 06 | Nektar Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) | RE |
| Mar. 03 | Intellia Therapeutics Presents Longer-Term Clinical Data For Lonvoguran Ziclumeran | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Official Publications
Select your edition
All financial news and data tailored to specific country editions
